Risk factors of pulmonary arterial hypertension in patients with scleroderma and systemic lupus erythematosus
Main Article Content
Abstract
Echocardiography, the 6 - minute walking test, NT proBNP and NYHA are valuable for screening and assessing severe scleroderma, systemic lupus erythematosus. This study was conducted to evaluate the rick factors related pulmonary arterial hypertension among scleroderma, systemic lupus erythematosus. A cross - sectional descriptive study on 137 patients with SLE and 62 patients with SSc, including 138 patients without PAH and 61 patients with PAH ( > 36mmHg), was conducted at the Center of Allergy - Clinical Immunology. Bach Mai Hospital, National Institute of Dermatology, from August 2016 to August 2020. Results showed that level NT proBNP, and NYHA score in patients with PAH were higher, while the 6 minutes walking test were shorter. NT proBNP and NYHA score were the risk factors related to PAH.
Article Details
Keywords
pulmonary arterial hypertension, scleroderma, systemic lupus erythematosus, NT - proBNP, NYHA.
References
2. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine. 2006;85 (3):147 - 156.
3. Chen H - A, Hsu T - C, Yang S - C, et al. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study. Arthritis Research & Therapy. 2019;21 (1):82.
4. Demir R, Küçükoğlu MS. Six - minute walk test in pulmonary arterial hypertension. Anatolian journal of cardiology. 2015;15 (3):249.
5. Williams MH, Handler CE, Akram R, et al. Role of N - terminal brain natriuretic peptide (N - TproBNP) in scleroderma - associated pulmonary arterial hypertension. European heart journal. 2006;27 (12):1485 - 1494.
6. Gan T, McCann GP, Marcus JT, et al. NT - proBNP reflects right ventricular structure and function in pulmonary hypertension. European Respiratory Journal. 2006.
7. Shang X, Xiao S, Dong N, et al. Assessing right ventricular function in pulmonary hypertension patients and the correlation with the New York Heart Association (NYHA) classification. Oncotarget. 2017;8 (52):90421.
8. Rosa R, Santos AS, Coelho R, et al. The relation of six - minute walk test and lung function in interstitial lung disease. Eur Respiratory Soc; 2013.
9. Allanore Y, Borderie D, Meune C, et al. N - terminal pro - brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium - channel blockers. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2003;48 (12):3503 - 3508.
10. Ghofraniha L, Mirfeizi Z, Khabbaz FS, Vakilian F, Eslami S. Correlation of echocardiographic findings of pulmonary hypertension with six - minute walk test and plasma pro b - type natriuretic peptide level in systemic lupus erythematous. Electronic physician. 2017;9 (8):5122.
11. Pamidi S, Mehta S. Relationship between the six - minute walk test and cardiopulmonary exercise test parameters in connective tissue disease - associated pulmonary arterial hypertension. Chest. 2006;130 (4):120S.
12. Farber HW, Miller DP, McGoon MD, Frost AE, Benton WW, Benza RL. Predicting outcomes in pulmonary arterial hypertension based on the 6 - minute walk distance. The Journal of Heart and Lung Transplantation. 2015;34 (3):362 - 368.
13. Galiè N, Humbert M, Vachiery J - L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European heart journal. 2015;37 (1):67 - 119.